Abietane diterpenes from Abies spectabilis and their anti-pancreatic cancer activity against the MIA PaCa-2 cell line

Bioorg Med Chem Lett. 2022 Jun 15:66:128723. doi: 10.1016/j.bmcl.2022.128723. Epub 2022 Apr 6.

Abstract

An ethanolic extract of the stem of Abies spectabilis exhibited strong cytotoxicity against MIA PaCa-2 human pancreatic cancer cells preferentially under nutrient-deprived conditions. Therefore, phytochemical investigation of this bioactive extract was carried out, and that led the isolation of ten compounds (1-10) including a new abietane-type diterpene (1). The structure of the new compound (1) was elucidated by combined spectroscopic techniques, including HRFABMS, NMR and quantum ECD calculation. All the isolated compounds were evaluated for their efficacy against MIA PaCa-2 human pancreatic cancer cell line by employing an anti-austerity strategy. Among the tested compounds, dehydroabietinol (5) displayed the most potent activity with a PC50 value of 6.6 μM. Dehydroabietinol (5) was also found to retard the MIA PaCa-2 cell migration under normal nutrient-rich conditions displaying its anti-metastatic potential. Investigation on the mechanism suggested that dehydroabietinol (5) is an inhibitor of the key cancer cell survival Akt/mTOR/autophagy signaling pathway.

Keywords: Abies spectabilis; Abietane; Diterpenes; MIA PaCa-2; Preferential cytotoxicity.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Abies*
  • Abietanes / pharmacology
  • Antineoplastic Agents, Phytogenic* / chemistry
  • Cell Line, Tumor
  • Drug Screening Assays, Antitumor
  • Humans
  • Molecular Structure
  • Pancreatic Neoplasms* / drug therapy
  • Pancreatic Neoplasms* / pathology
  • Plant Extracts / therapeutic use

Substances

  • Abietanes
  • Antineoplastic Agents, Phytogenic
  • Plant Extracts